Clinical data was reported for the first time in patients receiving an 8 mg dose per injection (Cohort 9 of the dose escalation portion of RESOLVE), the highest dose planned in this trial. Patients in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback